Thrivent Financial for Lutherans
Position in DNLI — Denali Therapeutics Inc.
CIK 314984
Minneapolis, MN
Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$837,313
+$212,258 QoQ
Shares Held
32,555
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#135
of 290 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $349,109,214 across 50 Biotechnology names. DNLI ranks #36 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in DNLI
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $837,313 | 32,555 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $625,055 | 32,555 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $537,482 | 32,555 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $517,187 | 35,619 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $950,158 | 67,917 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $923,331 | 67,917 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $1,894,768 | 92,972 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,045,049 | 138,862 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $3,030,302 | 130,504 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,329,182 | 64,775 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $636,975 | 29,682 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||